| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.8 | 0.002 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.33 | 0.06 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.29 | 0.07 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.28 | 0.08 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.28 | 3e-08 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.27 | 0.06 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.26 | 5e-14 |